Cost-effectiveness of applying high-sensitivity troponin I to a score for cardiovascular risk prediction in asymptomatic population
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0307468 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Paul Jülicher und 24 weiteren Autor:innen. Beteiligte Einrichtung: Medical Affairs, Core Diagnostics, Abbott, Abbott Park, IL, United States of America. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Cardiovascular Diseases, Troponin I. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Center of Cardiovascular Research, MORGAM, GenomEUtwin.
Abstract (Originalsprache)
Introduction
Risk stratification scores such as the European Systematic COronary Risk Evaluation (SCORE) are used to guide individuals on cardiovascular disease (CVD) prevention. Adding high-sensitivity troponin I (hsTnI) to such risk scores has the potential to improve accuracy of CVD prediction. We investigated how applying hsTnI in addition to SCORE may impact management, outcome, and cost-effectiveness.
Methods
Characteristics of 72,190 apparently healthy individuals from the Biomarker for Cardiovascular Risk Assessment in Europe (BiomarCaRE) project were included into a discrete-event simulation comparing two strategies for assessing CVD risk. The standard strategy reflecting current practice employed SCORE (SCORE); the alternative strategy involved adding hsTnI information for further stratifying SCORE risk categories (S-SCORE). Individuals were followed over ten years from baseline examination to CVD event, death or end of follow-up. The model tracked the occurrence of events and calculated direct costs of screening, prevention, and treatment from a European health system perspective. Cost-effectiveness was expressed as incremental cost-effectiveness ratio (ICER) in € per quality-adjusted life year (QALYs) gained during 10 years of follow-up. Outputs were validated against observed rates, and results were tested in deterministic and probabilistic sensitivity analyses.
Results
S-SCORE yielded a change in management for 10.0% of individuals, and a reduction in CVD events (4.85% vs. 5.38%, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Affairs, Core Diagnostics, Abbott, Abbott Park, IL, United States of America.
- Midwifery Science-Health Care Research and Prevention, Institute for Health Service Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany.
- Department of General and Interventional Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.
- Institute of Epidemiology, German Research Center for Environmental Health, Helmholtz Zentrum München, Neuherberg, Germany.
- German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, München, Germany.
ORCID-Profile: Paul Jülicher, Nataliya Makarova, Torben Jørgensen, Allan Linneberg, Veikko Salomaa, Simona Costanzo, Kari Kuulasmaa, Tarja Tuovinen
Förderung
- German Center of Cardiovascular Research
- MORGAM
- GenomEUtwin
- ENGAGE
- CHANCES
- BiomarCaRE
- euCanSHare
- AFFECT-EU
Zitieren
APA
Jülicher, P., Makarova, N., Ojeda, F., Giusepi, I., Peters, A., Thorand, B., Cesana, G., Jørgensen, T., Linneberg, A., Salomaa, V., Iacoviello, L., Costanzo, S., Söderberg, S., Kee, F., Giampaoli, S., Palmieri, L., Donfrancesco, C., Zeller, T., Kuulasmaa, K., …, & Siebert, U. (2024). Cost-effectiveness of applying high-sensitivity troponin I to a score for cardiovascular risk prediction in asymptomatic population. PLOS ONE. https://doi.org/10.1371/journal.pone.0307468
Vancouver
Jülicher P, Makarova N, Ojeda F, Giusepi I, Peters A, Thorand B, et al. Cost-effectiveness of applying high-sensitivity troponin I to a score for cardiovascular risk prediction in asymptomatic population. PLOS ONE. 2024. doi:10.1371/journal.pone.0307468
BibTeX
@article{Jlicher2024,
author = {Jülicher, Paul and Makarova, Nataliya and Ojeda, Francisco and Giusepi, Isabella and Peters, Annette and Thorand, Barbara and Cesana, Giancarlo and Jørgensen, Torben and Linneberg, Allan and Salomaa, Veikko and Iacoviello, Licia and Costanzo, Simona and Söderberg, Stefan and Kee, Frank and Giampaoli, Simona and Palmieri, Luigi and Donfrancesco, Chiara and Zeller, Tanja and Kuulasmaa, Kari and Tuovinen, Tarja and Lamrock, Felicity and Conrads-Frank, Annette and Brambilla, Paolo and Blankenberg, Stefan and Siebert, Uwe},
title = {Cost-effectiveness of applying high-sensitivity troponin I to a score for cardiovascular risk prediction in asymptomatic population},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0307468}
}
EUVIMED